(EMAILWIRE.COM, January 30, 2017 ) According to Publisher, the Global Smart Insulin Pens market is accounted for $XX million in 2015 and is expected to reach $XX million by 2022 growing at a CAGR of XX%. Rising diabetic population and advancements in insulin delivery technologies are the factors fueling the market. Also, increasing adoption of smartphones which has made treatment easy is other major factor fueling the market. However, high cost of pens compared to injections and availability of alternative treatments may hamper the market growth. North America accounted for the largest share followed by Europe owing to growing aging population, increased funding for patients by health insurance companies and technological advancements.

For more information about this report: http://www.reportsweb.com/smart-insulin-pens-global-market-outlook-2016-2022

Some of the key players in Global Smart Insulin Pens market include Vigihealth, Novo Nordisk A/S, Eli Lilly And Company, Jiangsu Delfu Medical Device Co.,Ltd, Emperra Gmbh and Digital Medics Ptd Ltd.

Fabrication Material Covered:
- Plastic
- Metal

Technologies Covered:
- Jet Injectors
- Bluetooth
- Spring Loaded

End Users Covered:
- Retail Pharmacies
- E-commerce
- Hospital Pharmacies
- Drugstores

Products Covered:
- Accessories
o Pen Needles
o Timesulin Pen Cap
o Insulin Cartridge
- Prefilled/ Disposable Insulin Pens
- Reusable/ Durable Insulin Pens

Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001564943/sample

Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Company Profiling
11.1 Vigihealth
11.2 Novo Nordisk A/S
11.3 Eli Lilly And Company
11.4 Jiangsu Delfu Medical Device Co.,Ltd
11.5 Emperra Gmbh
11.6 Digital Medics Ptd Ltd

Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001564943/buying

Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results